BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20585842)

  • 1. Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.
    Xia D; Cui F; Piao H; Cun D; Piao H; Jiang Y; Ouyang M; Quan P
    Pharm Res; 2010 Sep; 27(9):1965-76. PubMed ID: 20585842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
    Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
    Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.
    Quan P; Xia D; Piao H; Piao H; Shi K; Jia Y; Cui F
    AAPS PharmSciTech; 2011 Dec; 12(4):1136-43. PubMed ID: 21892695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Kumar VV; Chandrasekar D; Ramakrishna S; Kishan V; Rao YM; Diwan PV
    Int J Pharm; 2007 Apr; 335(1-2):167-175. PubMed ID: 17161566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
    Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
    Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus LacipilĀ®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the particle size effect of andrographolide suspensions on their IVIVC performance in oral absorption.
    Yao S; Chen N; Li M; Wang Q; Sun X; Feng X; Chen Y
    Eur J Pharm Biopharm; 2022 Oct; 179():65-73. PubMed ID: 36058447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: the critical size in improving bioavailability.
    Fu Q; Kou L; Gong C; Li M; Sun J; Zhang D; Liu M; Sui X; Liu K; Wang S; He Z
    Int J Pharm; 2012 May; 427(2):358-64. PubMed ID: 22370475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of solid dispersions of nitrendipine prepared with fine silica particles using the melt-mixing method.
    Wang L; Cui FD; Sunada H
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):37-43. PubMed ID: 16394546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism.
    Xia D; Ouyang M; Wu JX; Jiang Y; Piao H; Sun S; Zheng L; Rantanen J; Cui F; Yang M
    Pharm Res; 2012 Jan; 29(1):158-69. PubMed ID: 21748536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions.
    Li W; Quan P; Zhang Y; Cheng J; Liu J; Cun D; Xiang R; Fang L
    Int J Pharm; 2014 Jan; 460(1-2):13-23. PubMed ID: 24184036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Drug Target; 2006 Nov; 14(9):632-45. PubMed ID: 17090399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
    Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
    Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.
    Jinno J; Kamada N; Miyake M; Yamada K; Mukai T; Odomi M; Toguchi H; Liversidge GG; Higaki K; Kimura T
    J Control Release; 2006 Mar; 111(1-2):56-64. PubMed ID: 16410029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro/in vivo evaluation of felodipine nanosuspension.
    Sahu BP; Das MK
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):183-93. PubMed ID: 24198215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
    Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
    J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.